118. The role of copeptin in the prognosis of ischemic stroke

Article type: Letter to Editor                                                                                    

Article title: The role of copeptin in the prognosis of ischemic stroke

 

Journal: Journal of Current Research in Scientific Medicine

Year: 2022

Authors: Jamir Pitton Rissardo, Ana Letícia Fornari Caprara

E-mail: jamirrissardo@gmail.com

 

ABSTRACT

Copeptin, also known as CT-proAVP, is an amino acid usually derived from arginine vasopressin. It has been used as a prognostic biomarker in several conditions including heart failure, myocardial infarction, shock, sepsis, pneumonia, lower respiratory tract infections, and traumatic brain injury. Furthermore, copeptin was assessed for functional outcome and death in patients with cerebrovascular accidents. Herein, we would like to discuss the possible pathophysiology process involving copeptin and stroke. The receptors and their site of action were selected based on the mechanism of cerebrovascular events. It is worthy of mentioning that vasopressin is equimolar to copeptin, so both hormones may influence this pathway.

Keywords: Copeptin, ischemic stroke, stroke severity, biomarkers, outcomes

 

Full text available at:

https://www.jcrsmed.org/article.asp?issn=2455-3069;year=2022;volume=8;issue=1;spage=85;epage=86;aulast=Rissardo

 

DOI

10.4103/jcrsm.jcrsm_91_21

 

Citation

Rissardo JP, Caprara AL. The role of copeptin in the prognosis of ischemic stroke. J Curr Res Sci Med 2022;8:85-6